An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure

This work was supported by the NIHR Health Protection Research Unit in Respiratory Infections, United Kingdom, NIHR Imperial College London, United Kingdom (Grant number: NIHR200927; AL) in partnership with the UK Health Security Agency and the NIHR Medical Research Council (MRC), United Kingdom (Grant number: MR/X004058/1). Support for sequencing was provided by the Imperial BRC Genomics Facility which is funded by the NIHR, United Kingdom. The development of the hybrid DABA assay used for quantification of SARS-CoV-2 anti-Spike RBD antibodies was supported by the MRC (MC_PC_19078).

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2024-12-11
DOI
https://doi.org/10.1016/j.ebiom.2024.105475
Citations
9
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
3.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure

Kieran Madon, Myra O. McClure, Robert Varro, Sean Nevin et al.
9 citations
EBioMedicine
SARS-CoV-2 and COVID-19 Research
3.50
article

An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure

Kieran Madon, Myra O. McClure, Robert Varro, Sean Nevin, Seran Hakki, Richard S. Tedder, Aleksandra Koycheva, Timesh D Pillay, Emily Conibear, John S. Tregoning, Nieves Derqui, Graham P. Taylor, Romain Derelle, Ryan S. Thwaites, Jakob Jonnerby, Ajit Lalvani, Samuel Baldwin, Anjna Badhan, Eleanor Parker, Mica Tolosa-Wright, Carolina Rosadas, Lulu Wang, Joe Fenn, Constanta Luca, Rhia Kundu
article en
9 citations

Abstract

This work was supported by the NIHR Health Protection Research Unit in Respiratory Infections, United Kingdom, NIHR Imperial College London, United Kingdom (Grant number: NIHR200927; AL) in partnership with the UK Health Security Agency and the NIHR Medical Research Council (MRC), United Kingdom (Grant number: MR/X004058/1). Support for sequencing was provided by the Imperial BRC Genomics Facility which is funded by the NIHR, United Kingdom. The development of the hybrid DABA assay used for quantification of SARS-CoV-2 anti-Spike RBD antibodies was supported by the MRC (MC_PC_19078).

EBioMedicineVol. 111
NIHR Imperial Biomedical Research Centre (GB), Imperial College London (GB)
National Institute for Health Research Health Protection Research Unit, National Institute for Health and Care Research, Imperial College London, Medical Research Council
Good health and well-being
Openalex Percentile: Top 6%
SARS-CoV-2 and COVID-19 Research
3.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.